Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Accelerated BEP Chemotherapy for Intermediate and High Risk Metastatic Germ Cell Tumor
NCT00453232Phase 2Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Aug 2004
- Primary completion
- Dec 2008
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bleomycin, etoposide, cisplatin, pegfilgrastim in germ cell tumor (GCT), sponsored by Cambridge University Hospitals NHS Foundation Trust. Started Aug 2004; status: completed.
02
Drugs
bleomycinetoposidecisplatinpegfilgrastim
03
Conditions
germ cell tumor (GCT)
Beyond the preview
Go deeper on NCT00453232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00453232.